Literature DB >> 32084507

Sex-determining region Y box 4 (SOX4) suppresses Hepatitis B virus replication by inhibiting hepatocyte nuclear factor 4α expression.

Shu Shi1, Mingchen Liu1, Jingyuan Xi1, Hui Liu1, Guiwen Guan1, Congle Shen1, Zhengyang Guo1, Ting Zhang1, Qiang Xu1, Dilidaer Kudereti2, Xiangmei Chen1, Jie Wang3, Fengmin Lu4.   

Abstract

Hepatitis B virus (HBV) infection is still a health care crisis in the world, and a considerable number of chronic hepatitis B patients die of end-stage liver diseases, including liver cirrhosis and hepatocellular carcinoma. A previous study has reported that sex-determining region Y box 4 (SOX4) promotes HBV replication by binding to the AACAAAG motif in the viral genome. However, such SOX4 binding site was not found in the genome of the majority of HBV genotype strains. Further, we found that SOX4 inhibited rather than promoted the replication of most HBV strains. In line with this, HBV replication was significantly enhanced when the endogenous SOX4 was knocked down. Moreover, we demonstrated that the SOX4-induced suppression of HBV replication was mainly mediated by hepatocyte nuclear factor 4α (HNF4α). Taken together, our findings suggest that SOX4 plays an important antiviral role by inhibiting HNF4α expression in most HBV strains.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32084507     DOI: 10.1016/j.antiviral.2020.104745

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  4 in total

Review 1.  Advance of SOX Transcription Factors in Hepatocellular Carcinoma: From Role, Tumor Immune Relevance to Targeted Therapy.

Authors:  Xiangyuan Luo; Xiaoyu Ji; Meng Xie; Tongyue Zhang; Yijun Wang; Mengyu Sun; Wenjie Huang; Limin Xia
Journal:  Cancers (Basel)       Date:  2022-02-24       Impact factor: 6.639

2.  HBx 128-133 Deletion Affecting HBV Mother-to-Child Transmission Weakens HBV Replication via Reducing HBx Level and CP/ENII Transcriptional Activity.

Authors:  Yarong Song; Ying Lu; Yi Li; Minmin Liu; Hui Zhuang; Jie Li; Jie Wang
Journal:  Viruses       Date:  2022-08-26       Impact factor: 5.818

3.  Neddylation inhibitor MLN4924 has anti-HBV activity via modulating the ERK-HNF1α-C/EBPα-HNF4α axis.

Authors:  Mingjie Xie; Huiting Guo; Guohua Lou; Jiping Yao; Yanning Liu; Yi Sun; Zhenggang Yang; Min Zheng
Journal:  J Cell Mol Med       Date:  2020-12-02       Impact factor: 5.295

4.  Multi-omic profiling of plasma reveals molecular alterations in children with COVID-19.

Authors:  Chong Wang; Xufang Li; Wanshan Ning; Sitang Gong; Fengxia Yang; Chunxiao Fang; Yu Gong; Di Wu; Muhan Huang; Yujie Gou; Shanshan Fu; Yujie Ren; Ruyi Yang; Yang Qiu; Yu Xue; Yi Xu; Xi Zhou
Journal:  Theranostics       Date:  2021-07-06       Impact factor: 11.556

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.